Kamiya recalls K-ASSAY IgA Immunoturbidimetric Assay (REF: KAI-013) due to cloudiness that can affect test accuracy. Affected units have specific lot numbers and expiration dates.
IgA Reagent may start showing cloudiness over time, which can affect assay performance.
Kamiya is recalling its K-ASSAY IgA Immunoturbidimetric Assay (REF: KAI-013) because the reagent may develop cloudiness over time, which can lead to inaccurate test results. This issue affects specific batches with known expiration dates and lot numbers.
The IgA reagent may become cloudy over time, which can cause the test results to be inaccurate. This cloudiness is a gradual change that occurs in the reagent solution.
Lab users who purchased the K-ASSAY IgA Immunoturbidimetric Assay (REF: KAI-013) with lot numbers H180, K181, N182, or D283 are most at risk. These units have expiration dates through January 2023 to September 2023.
Check the product label for the lot number (H180, K181, N182, or D283) and expiration date (through January 2023 to September 2023). The product is sold under the reference number KAI-013.
Look for the lot number (H180, K181, N182, or D283) and expiration date on the product label.
Kamiya Biomedical Company, LLC recalls K-ASSAY IgA Immunoturbidimetric Assay (REF: KAI-013).
The IgA reagent may start showing cloudiness over time, which can affect assay performance.
Lot numbers H180 (expires Jan 2023), K181 (Mar 2023), N182 (Jun 2023), and D283 (Sep 2023).
We’ve drafted a message you can send Kamiya to request your refund or repair — edit it as you like.
Subject: Recall Z-0271-2023 — Kamiya Kamiya Hello, I own a Kamiya that is covered by recall Z-0271-2023 from Kamiya. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.